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Diabetic patients have impaired heart rate control. In diabetic rats ex vivo heart rate was significantly decreased compared to non-diabetic animals. Why this is the case remains unknown.
Within sinoatrial nodal cardiomyocytes heart rate is determined by rhythmic oscillations in Ca 2+ and other ions, the so called Ca 2+ and membrane clocks. The Ca 2+ clock primarily involves the intracellular Ca 2+ store, the sarcoplasmic reticulum, and 'Ca 2+ -handling' proteins such as the sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA2a) and its regulator phospholamban (PLB). The membrane clock involves membrane ion transporters such as the hyperpolarisation-activated cyclic nucleotide-gated channel (HCN4) and Na + -Ca 2+ exchanger (NCX).
The aim of this research was to investigate whether the reduced intrinsic heart rate in diabetes is due to changes in the Ca 2+ and/ or membrane clocks.
The sinoatrial node of non-diabetic and type 2 diabetic rats was isolated and protein expression was determined. A significant 1.6-fold increase in PLB expression was found in DM (p < 0.05), with no change to SERCA2a expression (p > 0.05). A significant 2.2-fold increase in NCX expression (p < 0.05) and a trend towards an increase in HCN4 (p = 0.08) in DM was found. The functional effects on heart rate were investigated by increasing external Ca 2+ and ivabradine (HCN4 inhibitor) concentrations in isolated Langendorff hearts. Changes in external Ca 2+ did not change intrinsic heart rate in both groups, however ivabradine reduced intrinsic heart rate in nDM, but not in DM.
We conclude the lower intrinsic heart rate in diabetic rats is, in part, a result of change in membrane clock proteins (nonfunctional HCN4). Background: We assessed the cycle length (CL) of ventricular tachycardia (VT) induced at electrophysiology study (EPS) early post-MI with spontaneous VT at follow up in implantable-cardioverter defibrillator (ICD) recipients.
Methods: Consecutive STEMI patients with left ventricular ejection fraction (LVEF) ≤40% underwent EPS as part of a study protocol targeting early (within 40 days) prevention of sudden cardiac death (SCD). The CL of induced VT at EPS was compared with first spontaneous VT and subsequent VT in ICD recipients at follow up. Secondary endpoints included mortality, sudden cardiac death (SCD) and cardiac arrest.
Results: EPS performed early post-MI in 403 patients was negative in 68.5% (n = 276) and positive in 31.5% (n = 127). In patients with a positive EPS, induced monomorphic VT had mean CL 229 ± 29 milliseconds. Primary prevention ICD was implanted in 120/127 patients with a positive EPS. In EPS positive patients with an ICD, 33% had an appropriate activation due to either VF (n = 5) or VT (n = 35) mean CL 308 ± 47 milliseconds at mean 3.4 ± 2.7 years post-STEMI. In individual patients the induced VT CL at EPS did not correlate with first spontaneous VT CL (r = 0.09, p = 0.60) but instead the VT CL lengthened with time post-MI (r = 0.481, p < 0.001). Total mortality occurred in 15.7% and 5.1% of EPS positive and negative patients, respectively (p = 0.001).
Conclusions: In patients post-MI with LVEF ≤40% and inducible VT at early EPS, the first episode of spontaneous VT at follow up in ICD recipients was significantly slower to what was induced. This is potentially related to the myocardial remodelling process post-MI. The Canberra Hospital, Canberra, Australia Introduction: The benefits of an implantable cardioverterdefibrillator (ICD) in significantly reducing sudden cardiac death in ischaemic (ICM) and non-ischaemic cardiomyopathy (NICM) patients has been well demonstrated. Our study investigated the characteristics of ventricular tachycardias (VT) between ICM and NICM patients who received ICD therapy.
